Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYEyePoint Pharmaceuticals Strengthens Executive Leadership Team with Key HiresPREV STORYRoche and Spark Therapeutics, Inc. receive Request for Additional Information from FTC under Hart-Scott-Rodino Act and announce extension of tender offer for shares of Spark Therapeutics, Inc.
